Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.

Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome. J Hematol Oncol. 2009 May 13; 2:20.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Dose-Response Relationship, Drug
Female
Glutathione
Humans
Hydrochloric Acid
Injections
Liposomes
Male
Middle Aged
Myelodysplastic Syndromes
Prodrugs
Young Adult

authors with profiles

Richard A. Larson